Insider · CIK 0001812942
Eugene Durenard
Files at CODX (Co-Diagnostics, Inc.). First filing -, latest -.
In brief
Eugene Durenard files SEC Form 4 as director at CODX (Co-Diagnostics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Eugene Durenard has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +1,695 | $0.00 | $0 | 10,668 | May 27, 2026 |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -1,695 | $0.00 | $0 | 4,000 | May 27, 2026 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +57,499 | $0.00 | $0 | 269,166 | Nov 24, 2025 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -57,499 | $0.00 | $0 | 170,834 | Nov 24, 2025 |
| Aug 13, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Restricted Stock Unitsderivative | +125,000 | $0.00 | $0 | 228,333 | Aug 15, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +48,334 | $0.00 | $0 | 211,667 | May 27, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -48,334 | $0.00 | $0 | 103,333 | May 27, 2025 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +48,333 | $0.00 | $0 | 163,333 | Nov 25, 2024 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -48,333 | $0.00 | $0 | 151,667 | Nov 25, 2024 |
| May 23, 2024 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 115,000 | May 28, 2024 |
| May 23, 2024 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -30,000 | $0.00 | $0 | 200,000 | May 28, 2024 |
| Apr 26, 2024 | CODX Co-Diagnostics, Inc. | AGrant or award Restricted Stock Unitsderivative | +110,000 | $0.00 | $0 | 230,000 | Apr 29, 2024 |
| Nov 23, 2023 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 85,000 | Nov 27, 2023 |
| Nov 23, 2023 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -30,000 | $0.00 | $0 | 120,000 | Nov 27, 2023 |
Questions about Eugene Durenard
Answered from the filings on this page, as of the latest one.
Is Eugene Durenard buying or selling?
Eugene Durenard has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Eugene Durenard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eugene Durenard has 0.
Where does Eugene Durenard file Form 4?
Eugene Durenard has filed Form 4 at CODX (Co-Diagnostics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.